Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-33 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate |
1997-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2000-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2000510821-A |
titleOfInvention |
Diabetes treatment |
abstract |
(57) [Summary]nTreating Type I or Type II diabetes by using a peptide comprising an amino acid sequence corresponding to the amino acid sequence of an active C-terminal fragment of β-endorphin or an active analog of a C-terminal fragment of β-endorphin . |
priorityDate |
1996-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |